View ValuationThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsCBTX 将来の成長Future 基準チェック /56主要情報100.7%収益成長率49.23%EPS成長率Banks 収益成長8.3%収益成長率73.4%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日n/a今後の成長に関する最新情報Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.すべての更新を表示Recent updatesRecent Insider Transactions Derivative • Sep 27Senior EVP & CCO exercised options to buy US$192k worth of stock.On the 23rd of September, Joe West exercised options to buy 6k shares at a strike price of around US$11.32, costing a total of US$73k. This transaction amounted to 11% of their direct individual holding at the time of the trade. Since March 2022, Joe's direct individual holding has increased from 49.01k shares to 57.84k. Company insiders have collectively bought US$237k more than they sold, via options and on-market transactions, in the last 12 months.Seeking Alpha • Sep 22CBTX declares $0.13 dividendCBTX (NASDAQ:CBTX) declares $0.13/share quarterly dividend, in line with previous. Forward yield 1.67% Payable Oct. 14; for shareholders of record Sept. 29; ex-div Sept. 28. See CBTX Dividend Scorecard, Yield Chart, & Dividend Growth.Buying Opportunity • Sep 21Now 20% undervaluedOver the last 90 days, the stock is up 15%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.Buying Opportunity • Aug 25Now 20% undervaluedOver the last 90 days, the stock is up 9.5%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.Reported Earnings • Jul 29Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: US$0.48 (up from US$0.48 in 2Q 2021). Revenue: US$38.3m (down 3.3% from 2Q 2021). Net income: US$11.7m (flat on 2Q 2021). Profit margin: 31% (up from 30% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 147%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Seeking Alpha • Jul 28CBTX GAAP EPS of $0.48 beats by $0.06, revenue of $38.42M misses by $1.13MCBTX press release (NASDAQ:CBTX): Q2 GAAP EPS of $0.48 beats by $0.06. Revenue of $38.42M (+11.3% Y/Y) misses by $1.13M.Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).Recent Insider Transactions • Jun 09Independent Director recently bought US$300k worth of stockOn the 3rd of June, Michael Havard bought around 10k shares on-market at roughly US$28.60 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$64k more in shares than they have sold in the last 12 months.Recent Insider Transactions Derivative • Jun 08Senior EVP & CCO exercised options to buy US$253k worth of stock.On the 4th of June, Joe West exercised options to buy 9k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 18% of their direct individual holding at the time of the trade. Since March 2022, Joe has owned 49.01k shares directly. Company insiders have collectively sold US$135k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • May 07Insider recently sold US$235k worth of stockOn the 5th of May, Deborah Dinsmore sold around 8k shares on-market at roughly US$28.70 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: US$0.43 (up from US$0.41 in 1Q 2021). Revenue: US$37.5m (up 4.8% from 1Q 2021). Net income: US$10.6m (up 5.7% from 1Q 2021). Profit margin: 28% (in line with 1Q 2021). Revenue exceeded analyst estimates by 6.2%. Earnings per share (EPS) also surpassed analyst estimates by 34%. Over the next year, revenue is forecast to grow 106%, compared to a 11% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Reagan Reaud was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).Reported Earnings • Mar 01Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$151.3m (up 25% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 24% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Net interest margin (NIM): 3.31% (down from 3.73% in FY 2020). Cost-to-income ratio: 75.6% (up from 64.2% in FY 2020). Non-performing loans: 0.78% (down from 0.82% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 77%, compared to a 5.8% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.Reported Earnings • Jan 29Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$153.2m (up 26% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 23% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 65%, compared to a 4.3% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS US$0.59 (vs US$0.26 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$41.7m (up 47% from 3Q 2020). Net income: US$14.4m (up 125% from 3Q 2020). Profit margin: 35% (up from 23% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 6% per year.Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS US$0.48 (vs US$0.087 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$39.6m (up 57% from 2Q 2020). Net income: US$11.7m (up 441% from 2Q 2020). Profit margin: 30% (up from 8.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 11% per year.Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).分析記事 • May 13Shareholders May Find It Hard To Justify A Pay Rise For CBTX, Inc.'s (NASDAQ:CBTX) CEO This YearThe share price of CBTX, Inc. ( NASDAQ:CBTX ) has struggled to grow by much over the last few years and probably has to...Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.Reported Earnings • May 03First quarter 2021 earnings released: EPS US$0.41 (vs US$0.30 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$35.8m (up 14% from 1Q 2020). Net income: US$10.0m (up 33% from 1Q 2020). Profit margin: 28% (up from 24% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Price Target Changed • Apr 10Price target increased to US$32.00Up from US$29.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$32.04. Stock is up 78% over the past year.Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).Reported Earnings • Mar 01Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.Analyst Estimate Surprise Post Earnings • Mar 01Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 18% growth forecast for the Banks industry in the US.分析記事 • Feb 25What Percentage Of CBTX, Inc. (NASDAQ:CBTX) Shares Do Insiders Own?A look at the shareholders of CBTX, Inc. ( NASDAQ:CBTX ) can tell us which group is most powerful. Institutions often...Is New 90 Day High Low • Feb 24New 90-day high: US$29.03The company is up 25% from its price of US$23.18 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$26.95 per share.Reported Earnings • Jan 30Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Net interest margin (NIM): 3.73% (down from 4.42% in FY 2019). Cost-to-income ratio: 64.2% (up from 58.3% in FY 2019). Non-performing loans: 0.82% (up from 0.04% in FY 2019). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 3% per year.Analyst Estimate Surprise Post Earnings • Jan 30Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 17% growth forecast for the Banks industry in the US.分析記事 • Jan 30CBTX, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsCBTX, Inc. ( NASDAQ:CBTX ) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to...Is New 90 Day High Low • Jan 23New 90-day high: US$28.70The company is up 44% from its price of US$19.88 on 23 October 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 30% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.41 per share.分析記事 • Jan 21Does CBTX, Inc. (NASDAQ:CBTX) Have A Place In Your Dividend Portfolio?Is CBTX, Inc. ( NASDAQ:CBTX ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...Is New 90 Day High Low • Jan 07New 90-day high: US$27.71The company is up 50% from its price of US$18.43 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.79 per share.Price Target Changed • Dec 29Price target raised to US$26.67Up from US$22.00, the current price target is an average from 3 analysts. The new target price is close to the current share price of US$26.26. As of last close, the stock is down 16% over the past year.分析記事 • Dec 26There's A Lot To Like About CBTX's (NASDAQ:CBTX) Upcoming US$0.10 DividendIt looks like CBTX, Inc. ( NASDAQ:CBTX ) is about to go ex-dividend in the next 4 days. This means that investors who...Upcoming Dividend • Dec 24Upcoming Dividend of US$0.10 Per ShareWill be paid on the 15th of January to those who are registered shareholders by the 31st of December. The trailing yield of 1.5% is below the top quartile of American dividend payers (4.0%), and is lower than industry peers (2.9%).分析記事 • Dec 23How Much Are CBTX, Inc. (NASDAQ:CBTX) Insiders Spending On Buying Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...Recent Insider Transactions Derivative • Dec 18Senior EVP exercised options to buy US$222k worth of stock.On the 15th of December, Robert Pigott exercised options to buy 8.83k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 16% of their direct individual holding at the time of the trade. Since March 2020, Robert has owned 55.95k shares directly. Company insiders have collectively bought US$2.9m more than they sold, via options and on-market transactions, in the last 12 months.Is New 90 Day High Low • Dec 16New 90-day high: US$24.62The company is up 51% from its price of US$16.34 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 23% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$27.77 per share.分析記事 • Dec 02Our Take On CBTX's (NASDAQ:CBTX) CEO SalaryBob Franklin became the CEO of CBTX, Inc. ( NASDAQ:CBTX ) in 2013, and we think it's a good time to look at the...Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 19% share price gain to US$21.87, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 15.9x. This compares to an average P/E of 11x in the Banks industry in the US. Total return to shareholders over the past three years is a loss of 21%.Is New 90 Day High Low • Nov 04New 90-day high: US$19.90The company is up 21% from its price of US$16.45 on 06 August 2020. The American market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.31 per share.Analyst Estimate Surprise Post Earnings • Oct 30Third-quarter earnings released: Revenue and earnings beat expectationsThird-quarter revenue exceeded analyst estimates by 0.3% at US$35.7m. Earnings per share (EPS) also surpassed analyst estimates by 1.3% at US$0.26. Revenue is forecast to grow 15% over the next year, compared to a 18% growth forecast for the Banks industry in the US.Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of US$28.8m, down 45% from the prior year. Total revenue was US$122.7m over the last 12 months, down 17% from the prior year.Is New 90 Day High Low • Oct 08New 90-day high: US$18.17The company is up 3.0% from its price of US$17.56 on 10 July 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$24.15 per share.Is New 90 Day High Low • Sep 22New 90-day low: US$15.00The company is down 23% from its price of US$19.36 on 24 June 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.70 per share.業績と収益の成長予測NasdaqGS:CBTX - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2023453168N/AN/A212/31/202223566N/AN/A16/30/2022150363131N/A3/31/2022152362525N/A12/31/2021151363435N/A9/30/2021150466667N/A6/30/2021140382740N/A3/31/2021126293246N/A12/31/2020121262740N/A9/30/2020126292740N/A6/30/2020132355457N/A3/31/2020142485456N/A12/31/2019146515456N/A9/30/2019148525658N/A6/30/2019146525053N/A3/31/2019145495152N/A12/31/2018141474849N/A9/30/2018132354444N/A6/30/2018128323939N/A3/31/2018126303332N/A12/31/2017122283636N/A9/30/2017122333334N/A6/30/2017116303838N/A3/31/2017114283537N/A12/31/2016113273636N/A12/31/201510524N/A33N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CBTXの予測収益成長率 (年間100.7% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: CBTXの収益 ( 100.7% ) はUS市場 ( 16.6% ) よりも速いペースで成長すると予測されています。高成長収益: CBTXの収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: CBTXの収益 ( 73.4% ) US市場 ( 11.5% ) よりも速いペースで成長すると予測されています。高い収益成長: CBTXの収益 ( 73.4% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CBTXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YBanks 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/02 03:42終値2022/09/30 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CBTX, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Christopher McGrattyKeefe, Bruyette, & WoodsBradley MilsapsPiper Sandler CompaniesMatthew OlneyStephens, Inc.
Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.
Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.
Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.
Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.
Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.
Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.
Recent Insider Transactions Derivative • Sep 27Senior EVP & CCO exercised options to buy US$192k worth of stock.On the 23rd of September, Joe West exercised options to buy 6k shares at a strike price of around US$11.32, costing a total of US$73k. This transaction amounted to 11% of their direct individual holding at the time of the trade. Since March 2022, Joe's direct individual holding has increased from 49.01k shares to 57.84k. Company insiders have collectively bought US$237k more than they sold, via options and on-market transactions, in the last 12 months.
Seeking Alpha • Sep 22CBTX declares $0.13 dividendCBTX (NASDAQ:CBTX) declares $0.13/share quarterly dividend, in line with previous. Forward yield 1.67% Payable Oct. 14; for shareholders of record Sept. 29; ex-div Sept. 28. See CBTX Dividend Scorecard, Yield Chart, & Dividend Growth.
Buying Opportunity • Sep 21Now 20% undervaluedOver the last 90 days, the stock is up 15%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.
Buying Opportunity • Aug 25Now 20% undervaluedOver the last 90 days, the stock is up 9.5%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.
Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.
Reported Earnings • Jul 29Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: US$0.48 (up from US$0.48 in 2Q 2021). Revenue: US$38.3m (down 3.3% from 2Q 2021). Net income: US$11.7m (flat on 2Q 2021). Profit margin: 31% (up from 30% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 147%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Seeking Alpha • Jul 28CBTX GAAP EPS of $0.48 beats by $0.06, revenue of $38.42M misses by $1.13MCBTX press release (NASDAQ:CBTX): Q2 GAAP EPS of $0.48 beats by $0.06. Revenue of $38.42M (+11.3% Y/Y) misses by $1.13M.
Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).
Recent Insider Transactions • Jun 09Independent Director recently bought US$300k worth of stockOn the 3rd of June, Michael Havard bought around 10k shares on-market at roughly US$28.60 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$64k more in shares than they have sold in the last 12 months.
Recent Insider Transactions Derivative • Jun 08Senior EVP & CCO exercised options to buy US$253k worth of stock.On the 4th of June, Joe West exercised options to buy 9k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 18% of their direct individual holding at the time of the trade. Since March 2022, Joe has owned 49.01k shares directly. Company insiders have collectively sold US$135k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • May 07Insider recently sold US$235k worth of stockOn the 5th of May, Deborah Dinsmore sold around 8k shares on-market at roughly US$28.70 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.
Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: US$0.43 (up from US$0.41 in 1Q 2021). Revenue: US$37.5m (up 4.8% from 1Q 2021). Net income: US$10.6m (up 5.7% from 1Q 2021). Profit margin: 28% (in line with 1Q 2021). Revenue exceeded analyst estimates by 6.2%. Earnings per share (EPS) also surpassed analyst estimates by 34%. Over the next year, revenue is forecast to grow 106%, compared to a 11% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Reagan Reaud was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Reported Earnings • Mar 01Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$151.3m (up 25% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 24% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Net interest margin (NIM): 3.31% (down from 3.73% in FY 2020). Cost-to-income ratio: 75.6% (up from 64.2% in FY 2020). Non-performing loans: 0.78% (down from 0.82% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 77%, compared to a 5.8% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.
Reported Earnings • Jan 29Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$153.2m (up 26% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 23% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 65%, compared to a 4.3% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).
Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.
Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.
Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS US$0.59 (vs US$0.26 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$41.7m (up 47% from 3Q 2020). Net income: US$14.4m (up 125% from 3Q 2020). Profit margin: 35% (up from 23% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 6% per year.
Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).
Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS US$0.48 (vs US$0.087 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$39.6m (up 57% from 2Q 2020). Net income: US$11.7m (up 441% from 2Q 2020). Profit margin: 30% (up from 8.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 11% per year.
Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).
分析記事 • May 13Shareholders May Find It Hard To Justify A Pay Rise For CBTX, Inc.'s (NASDAQ:CBTX) CEO This YearThe share price of CBTX, Inc. ( NASDAQ:CBTX ) has struggled to grow by much over the last few years and probably has to...
Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.
Reported Earnings • May 03First quarter 2021 earnings released: EPS US$0.41 (vs US$0.30 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$35.8m (up 14% from 1Q 2020). Net income: US$10.0m (up 33% from 1Q 2020). Profit margin: 28% (up from 24% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Price Target Changed • Apr 10Price target increased to US$32.00Up from US$29.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$32.04. Stock is up 78% over the past year.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Reported Earnings • Mar 01Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.
Analyst Estimate Surprise Post Earnings • Mar 01Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 18% growth forecast for the Banks industry in the US.
分析記事 • Feb 25What Percentage Of CBTX, Inc. (NASDAQ:CBTX) Shares Do Insiders Own?A look at the shareholders of CBTX, Inc. ( NASDAQ:CBTX ) can tell us which group is most powerful. Institutions often...
Is New 90 Day High Low • Feb 24New 90-day high: US$29.03The company is up 25% from its price of US$23.18 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$26.95 per share.
Reported Earnings • Jan 30Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Net interest margin (NIM): 3.73% (down from 4.42% in FY 2019). Cost-to-income ratio: 64.2% (up from 58.3% in FY 2019). Non-performing loans: 0.82% (up from 0.04% in FY 2019). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 3% per year.
Analyst Estimate Surprise Post Earnings • Jan 30Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 17% growth forecast for the Banks industry in the US.
分析記事 • Jan 30CBTX, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsCBTX, Inc. ( NASDAQ:CBTX ) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to...
Is New 90 Day High Low • Jan 23New 90-day high: US$28.70The company is up 44% from its price of US$19.88 on 23 October 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 30% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.41 per share.
分析記事 • Jan 21Does CBTX, Inc. (NASDAQ:CBTX) Have A Place In Your Dividend Portfolio?Is CBTX, Inc. ( NASDAQ:CBTX ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
Is New 90 Day High Low • Jan 07New 90-day high: US$27.71The company is up 50% from its price of US$18.43 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.79 per share.
Price Target Changed • Dec 29Price target raised to US$26.67Up from US$22.00, the current price target is an average from 3 analysts. The new target price is close to the current share price of US$26.26. As of last close, the stock is down 16% over the past year.
分析記事 • Dec 26There's A Lot To Like About CBTX's (NASDAQ:CBTX) Upcoming US$0.10 DividendIt looks like CBTX, Inc. ( NASDAQ:CBTX ) is about to go ex-dividend in the next 4 days. This means that investors who...
Upcoming Dividend • Dec 24Upcoming Dividend of US$0.10 Per ShareWill be paid on the 15th of January to those who are registered shareholders by the 31st of December. The trailing yield of 1.5% is below the top quartile of American dividend payers (4.0%), and is lower than industry peers (2.9%).
分析記事 • Dec 23How Much Are CBTX, Inc. (NASDAQ:CBTX) Insiders Spending On Buying Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Recent Insider Transactions Derivative • Dec 18Senior EVP exercised options to buy US$222k worth of stock.On the 15th of December, Robert Pigott exercised options to buy 8.83k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 16% of their direct individual holding at the time of the trade. Since March 2020, Robert has owned 55.95k shares directly. Company insiders have collectively bought US$2.9m more than they sold, via options and on-market transactions, in the last 12 months.
Is New 90 Day High Low • Dec 16New 90-day high: US$24.62The company is up 51% from its price of US$16.34 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 23% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$27.77 per share.
分析記事 • Dec 02Our Take On CBTX's (NASDAQ:CBTX) CEO SalaryBob Franklin became the CEO of CBTX, Inc. ( NASDAQ:CBTX ) in 2013, and we think it's a good time to look at the...
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 19% share price gain to US$21.87, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 15.9x. This compares to an average P/E of 11x in the Banks industry in the US. Total return to shareholders over the past three years is a loss of 21%.
Is New 90 Day High Low • Nov 04New 90-day high: US$19.90The company is up 21% from its price of US$16.45 on 06 August 2020. The American market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.31 per share.
Analyst Estimate Surprise Post Earnings • Oct 30Third-quarter earnings released: Revenue and earnings beat expectationsThird-quarter revenue exceeded analyst estimates by 0.3% at US$35.7m. Earnings per share (EPS) also surpassed analyst estimates by 1.3% at US$0.26. Revenue is forecast to grow 15% over the next year, compared to a 18% growth forecast for the Banks industry in the US.
Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of US$28.8m, down 45% from the prior year. Total revenue was US$122.7m over the last 12 months, down 17% from the prior year.
Is New 90 Day High Low • Oct 08New 90-day high: US$18.17The company is up 3.0% from its price of US$17.56 on 10 July 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$24.15 per share.
Is New 90 Day High Low • Sep 22New 90-day low: US$15.00The company is down 23% from its price of US$19.36 on 24 June 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.70 per share.